MERCOSUR Outlook: GMC/RES 25/21 and Argentina Regional Alignment
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
GMC/RES 25/21 is the MERCOSUR unified technical regulation on medical device registration, adopted in Montevideo on October 13, 2021. Under the synchronized entry-into-force mechanism of the Ouro Preto protocol, it will enter into force uniformly once all member states have completed their domestic incorporation; Argentina has already completed the transposition first (Disposición ANMAT 64/2025, published January 13, 2025), and the current guidance on the ANMAT website is applied under 64/2025 throughout.
This is not a matter for Argentina alone. It means that the classification rules, registration procedures, and documentation requirements for medical devices across the four Southern Cone countries are converging toward a single standard, and the window for planning the region as one board is opening. A dossier built now against this standard is an asset in every market that later adopts the same text, and the cost of ignoring the convergence grows with each market entered separately.
For manufacturers, the convergence changes the unit of planning. A regulatory strategy addressed country by country, with separate dossiers, separate classification rationales, and separate label developments, will keep paying a per-market premium for documents that could have been shared. A strategy built on the GMC 25/21 structures, by contrast, pays that premium once and reuses the result across the region. Argentina’s completed transposition makes it the natural place to build the reusable core, and for most portfolios the incremental cost of preparing to the regional standard, rather than to the national minimum, is small relative to the extension costs it avoids later.
2. Legal basis
| Regulation | Reference / number | Publication date | Provisions |
|---|---|---|---|
| MERCOSUR technical regulation on medical device registration | GMC/RES 25/21 | October 13, 2021 (adopted in Montevideo) | Annexes I–V; Part II Article 2; Part III Article 6; Part IV |
| Domestic transposition instrument (Argentina) | Disposición ANMAT 64/2025 | Published January 13, 2025 in the Official Gazette | Full text and annexes |
| Source of the transposition obligation | Protocol of Ouro Preto | 1994 | Provisions on the obligation to incorporate technical regulations |
| Repealed: former MERCOSUR technical regulation | GMC/RES 40/00 | 2000 | Full text (repealed by GMC 25/21) |
| MERCOSUR essential requirements | GMC/RES 72/98 | 1998 | Essential requirements of safety and effectiveness |
3. Expert insights
Insight 1: Argentina’s early transposition is a strategic asset. Because Argentina has completed its domestic transposition and applies GMC 25/21, an Argentine dossier prepared under the new rules is already aligned with the regional unified standard in its classification rationale, technical report format, and labeling elements. When extending later to the other member states, this dossier’s reusability is significantly higher than that of documents prepared under the old rules. The alignment is not superficial: the same classification logic, the same annex structures, and the same consistency expectations recur across the region, so early work compounds rather than expires.
Insight 2: The synchronized entry-into-force mechanism means regional unification is not yet complete, but the direction is settled. Formal entry into force awaits the unified notification by the Secretariat. Companies planning across multiple countries cannot assume the four states share one timetable, but they can prepare against one set of technical documentation, and that is the most valuable certainty available today. Sequencing decisions can be revisited as notifications arrive, while the core dossier work, done once, serves every scenario.
Insight 3: The high convergence between GMC 25/21 and the EU MDR lowers cross-region reuse costs. Definitions cover software, classification is rule-driven, and the technical documentation structure is clear. These characteristics make the conversion cost for CE-certified companies significantly lower than building from scratch. For companies positioning in both the EU and the Southern Cone, one core technical file can serve both regions, with the regional differences handled as targeted addenda rather than parallel authorships. The economies compound further as more MERCOSUR states complete transposition.
Insight 4: Convergence timelines reward early movers disproportionately. While the synchronized entry-into-force mechanism means no one can fix the regional launch date in advance, the direction of travel is not in doubt, and each subsequent transposition increases the value of a GMC-conformant dossier retroactively. A company that prepared its Argentine file to the regional standard holds, in effect, an option on every remaining market, exercisable at the cost of a country-specific submission rather than a fresh documentation project. Competitors that prepared nationally will face that documentation project precisely when the region’s demand for submissions peaks, since every manufacturer extends at once after the unified notification. Building to the regional standard early is therefore not conservative over-compliance but timing discipline on a known future event.
4. Practical recommendations
- Prepare the core technical documentation against GMC 25/21 rather than any single country’s rules. Compile the classification rationale, the technical report (Annex V), and labeling (Annex IV) to the regional unified standard, leaving interfaces for later extension.
- Use Argentina as the first or validation stop in the Southern Cone. Argentina has completed transposition with a clear interpretive line, making it the first stop for validating dossier quality and localization capability.
- Track the Secretariat’s unified entry-into-force notification. Once GMC 25/21 formally enters into force regionally, the submission lines of the other member states will align simultaneously; re-verify each country’s dossier immediately at that point.
- Plan the MERCOSUR footprint together with the global footprint. Sequence market access in Argentina, Brazil, Paraguay, and Uruguay in coordination with registration progress in the Chinese mainland, the EU, and the United States, avoiding duplicated investment.
5. Verification checklist
- □ It has been confirmed that GMC 25/21 was adopted on October 13, 2021 and replaced GMC 40/00
- □ It has been confirmed that Argentina completed the domestic transposition first through Disposición 64/2025
- □ The core technical documentation has been compiled in the GMC 25/21 annex formats
- □ A tracking mechanism for the MERCOSUR Secretariat’s unified entry-into-force notification has been established
- □ The feasibility of using Argentina as the Southern Cone first stop has been assessed
- □ The MERCOSUR footprint has been planned in coordination with global registration progress
- □ A mechanism for dossier reuse and difference statements across member states has been planned
Regulatory information verified as of October 29, 2026.
In Argentina, GRZAN operates a wholly owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.
The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience, tracking the developments of regulators worldwide. All external content follows the drafting standard of conclusions first, traceable basis, and verifiable numbers. For a market access plan tailored to your specific product for Argentina or the MERCOSUR region, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us